Ignite Creation Date:
2024-05-06 @ 7:51 PM
Last Modification Date:
2024-10-26 @ 3:14 PM
Study NCT ID:
NCT06150183
Status:
RECRUITING
Last Update Posted:
2024-07-05
First Post:
2023-11-21
Brief Title:
Safety and Preliminary Efficacy of BNT314 with or Without an Immune Checkpoint Inhibitor in Cancer Patients with Malignant Solid Tumors
Sponsor:
BioNTech SE
Organization:
BioNTech SE
Organization Data
Organization:
BioNTech SE
Class:
INDUSTRY
Study ID:
BNT314-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
BioNTech SE
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Genmab | INDUSTRY |